Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel agents for psychiatric disorders reported in recent patent literature

June 30, 2008

PN-277 shows benefit in experimental Parkinson's disease

June 30, 2008

ACR-325 advances into phase II PoC studies in PD, bipolar disorder

June 30, 2008

Hisamitsu files for approval in Japan of HFT-290 in cancer pain

June 30, 2008

CHMP recommends approval of Abstral for breakthrough cancer pain

June 30, 2008

CHMP issues positive opinion for UCB's Vimpat in epilepsy

June 30, 2008

CHMP issues positive opinion for Cymbalta in generalized anxiety disorder

June 30, 2008

New class of amyloid-inhibiting agents described

June 30, 2008

Phase III data show tasimelteon significantly improves sleep in insomnia

June 27, 2008

Recent patents describe novel analgesic agents

June 27, 2008

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...